关键词：抗菌药物；杀死；抑制；细菌生长；抗菌化合物
摘 要：Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Antibiotics Market in US

06.3.1 Market Size and Forecast

06.4 Antibiotics Market in Europe

06.4.1 Market Size and Forecast

06.5 Antibiotics Market in Asia

06.5.1 Market Size and Forecast

06.6 Five Forces Analysis

07. Market Segmentation by Mechanism of

Action

08. Market Segmentation by Chemical Structure

08.1 Market Segmentation by Drug Origin

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 AstraZeneca

18.1.1 Key Facts1

18.1.2 Business Description

18.1.3 Business Segmentation

18.1.4 Business Strategy

18.1.5 Revenue by Business Segmentation

18.1.6 Revenue Comparison 2011-2013

18.1.7 Sales Revenue by Geographical Segmentation

18.1.8 Key Developments

18.1.9 SWOT Analysis

18.2 GlaxoSmithKline

18.2.1 Key Facts

18.2.2 Business Overview

18.2.3 Business Segmentation

18.2.4 Business Segmentation by Revenue 2012 and 2013

18.2.5 Sales by Geography

18.2.6 Pipeline Products

18.2.7 Business Strategy

18.2.8 Key Information

18.2.9 SWOT Analysis

18.3 Eli Lilly

18.3.1 Key Fact

18.3.2 Business Overview

18.3.3 Business Segmentation by Revenue 2013

18.3.4 Business Segmentation by Revenue 2012 and 2013

18.3.5 Sales by Geography

18.3.6 Business Strategy

18.3.7 Key Developments

18.3.8 SWOT Analysis

18.4 Johnson & Johnson

18.4.1 Key Facts

18.4.2 Business Overview

18.4.3 Business Segmentation by Revenue 2013

18.4.4 Business Segmentation by Revenue 2012 and 2013

18.4.5 Geographical Segmentation by Revenue 2013

18.4.6 Business Strategy

18.4.7 Recent Developments

18.4.8 SWOT Analysis

18.5 Novartis

18.5.1 Key Facts

18.5.2 Business Overview

18.5.3 Business Segmentation by Revenue 2013

18.5.4 Business Segmentation by Revenue 2012 and 2013

18.5.5 Sales by Geography

18.5.6 Business Strategy

18.5.7 Key Developments

18.5.8 SWOT Analysis

18.6 Pfizer

18.6.1 Key Facts

18.6.2 Business Description

18.6.3 Business Segmentation

18.6.4 Revenue by Business Segmentation

18.6.5 Revenue Comparison 2012 and 2013

18.6.6 Sales by Geography

18.6.7 Business Strategy

18.6.8 Key Developments

18.6.9 SWOT Analysis

18.7 Sanofi

18.7.1 Key Facts

18.7.2 Business Overview

18.7.3 Business Segmentation by Revenue 2013

18.7.4 Business Segmentation by Revenue 2012 and 2013

18.7.5 Geographical Segmentation by Revenue 2013

18.7.6 Business Strategy

18.7.7 Key Developments

18.7.8 SWOT Analysis

19. Other Reports in this Series